Ontology type: schema:Chapter
2003
AUTHORSE. Di Bona , R. Sartori , T. Lerede , G. Rossi , M. Vespignani , F. Rodeghiero , T. Barbui , R. Bassan
ABSTRACTIdarubicin-based induction programs in acute lymphoblastic leukemia (ALL) account for 75%–85% of complete remission rate. A small amount of patients exhibit primary refractoriness, and about 60% of those achieving a remission eventually relapse. This study was aimed to review the clinical response to retreatment in ALL patients relapsing after or resistant to idarubicin-based induction. The “ABC” second-line regimen, consisted of a combination of high-dose methotrexate, methyl-prednisolone, vincristine and mitoxantrone. Twenty-eight patients (3 primary resistant, 25 at first relapse) were treated with two courses (“A” and “B”, the latter with reduced drug dosages) for remission (re)induction and early consolidation. Autologous or allogeneic bone marrow transplantation was then planned (“C”), depending on the availability of related/unrelated HLA-compatible donors. With cycle “A”, 68% of the patients (2/3 resistant and 17/25 relapsed) achieved a response; 4 were refractory (14%) and 5 (18%) died early. 58% of 19 responsive patients received course “B”, 2 underwent allogeneic BMT (1 refractory), one had an autograft, and 5 did not receive any further treatment. After course 2, 7/11 patients received course “C” (4 auto, 3 allo hematopoietic stem cell transplant). WHO grade 3-4 treatment-related toxicity, mostly gastroenteric (41%), developed in 50% and 25% of the cases during course „A“, and 36% of the cases during course „B“ (grade 3). The median duration of complete response was 118 days (18–327); overall survival from date of relapse/refractoriness was 187 days (15–530). Only two patients are alive in remission at 120+ and 170+ days, and 3 died in remission of toxic complications. The “ABC” salvage therapy was feasible and effective for induction of remission after Idarubicin-based programs. The short duration of the response so achieved raises the question of the best post-induction treatment. More... »
PAGES461-464
Acute Leukemias IX
ISBN
978-3-642-63949-4
978-3-642-59358-1
http://scigraph.springernature.com/pub.10.1007/978-3-642-59358-1_77
DOIhttp://dx.doi.org/10.1007/978-3-642-59358-1_77
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1001536473
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"name": [
"Hematology Department, Vicenza, Italy"
],
"type": "Organization"
},
"familyName": "Di Bona",
"givenName": "E.",
"id": "sg:person.0576406075.64",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576406075.64"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Vicenza, Italy"
],
"type": "Organization"
},
"familyName": "Sartori",
"givenName": "R.",
"id": "sg:person.0711542425.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711542425.52"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Bergamo, Italy"
],
"type": "Organization"
},
"familyName": "Lerede",
"givenName": "T.",
"id": "sg:person.01010005204.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010005204.78"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Brescia, Italy"
],
"type": "Organization"
},
"familyName": "Rossi",
"givenName": "G.",
"id": "sg:person.014455313102.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014455313102.84"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Venezia, Italy"
],
"type": "Organization"
},
"familyName": "Vespignani",
"givenName": "M.",
"id": "sg:person.01215261327.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215261327.70"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Vicenza, Italy"
],
"type": "Organization"
},
"familyName": "Rodeghiero",
"givenName": "F.",
"id": "sg:person.01132617604.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132617604.26"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Bergamo, Italy"
],
"type": "Organization"
},
"familyName": "Barbui",
"givenName": "T.",
"id": "sg:person.01265140742.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265140742.50"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Hematology Department, Bergamo, Italy"
],
"type": "Organization"
},
"familyName": "Bassan",
"givenName": "R.",
"id": "sg:person.0621654744.61",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621654744.61"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1016/s0145-2126(99)00148-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000418775"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/1097-0142(19890701)64:1<16::aid-cncr2820640104>3.0.co;2-o",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006934131"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0145-2126(99)00078-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021557591"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/(sici)1097-0142(19991001)86:7<1216::aid-cncr17>3.0.co;2-o",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025855964"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2400861",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028091408",
"https://doi.org/10.1038/sj.leu.2400861"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2400861",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028091408",
"https://doi.org/10.1038/sj.leu.2400861"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/10428199709039047",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032890430"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/(sici)1096-911x(199906)32:6<411::aid-mpo3>3.0.co;2-k",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033879834"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/1097-0142(19931001)72:7<2155::aid-cncr2820720715>3.0.co;2-v",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037974124"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/(sici)1097-0142(19980401)82:7<1387::aid-cncr24>3.0.co;2-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038335571"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1999.01258.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038674483"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1997.1102926.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041154821"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1997.1102926.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041154821"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2401058",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048337093",
"https://doi.org/10.1038/sj.leu.2401058"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2401058",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048337093",
"https://doi.org/10.1038/sj.leu.2401058"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077477083",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1078772986",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1082992388",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083175017",
"type": "CreativeWork"
}
],
"datePublished": "2003",
"datePublishedReg": "2003-01-01",
"description": "Idarubicin-based induction programs in acute lymphoblastic leukemia (ALL) account for 75%\u201385% of complete remission rate. A small amount of patients exhibit primary refractoriness, and about 60% of those achieving a remission eventually relapse. This study was aimed to review the clinical response to retreatment in ALL patients relapsing after or resistant to idarubicin-based induction. The \u201cABC\u201d second-line regimen, consisted of a combination of high-dose methotrexate, methyl-prednisolone, vincristine and mitoxantrone. Twenty-eight patients (3 primary resistant, 25 at first relapse) were treated with two courses (\u201cA\u201d and \u201cB\u201d, the latter with reduced drug dosages) for remission (re)induction and early consolidation. Autologous or allogeneic bone marrow transplantation was then planned (\u201cC\u201d), depending on the availability of related/unrelated HLA-compatible donors. With cycle \u201cA\u201d, 68% of the patients (2/3 resistant and 17/25 relapsed) achieved a response; 4 were refractory (14%) and 5 (18%) died early. 58% of 19 responsive patients received course \u201cB\u201d, 2 underwent allogeneic BMT (1 refractory), one had an autograft, and 5 did not receive any further treatment. After course 2, 7/11 patients received course \u201cC\u201d (4 auto, 3 allo hematopoietic stem cell transplant). WHO grade 3-4 treatment-related toxicity, mostly gastroenteric (41%), developed in 50% and 25% of the cases during course \u201eA\u201c, and 36% of the cases during course \u201eB\u201c (grade 3). The median duration of complete response was 118 days (18\u2013327); overall survival from date of relapse/refractoriness was 187 days (15\u2013530). Only two patients are alive in remission at 120+ and 170+ days, and 3 died in remission of toxic complications. The \u201cABC\u201d salvage therapy was feasible and effective for induction of remission after Idarubicin-based programs. The short duration of the response so achieved raises the question of the best post-induction treatment.",
"editor": [
{
"familyName": "Hiddemann",
"givenName": "Wolfgang",
"type": "Person"
},
{
"familyName": "Haferlach",
"givenName": "Torsten",
"type": "Person"
},
{
"familyName": "Unterhalt",
"givenName": "Michael",
"type": "Person"
},
{
"familyName": "B\u00fcchner",
"givenName": "Thomas",
"type": "Person"
},
{
"familyName": "Ritter",
"givenName": "J\u00f6rg",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-642-59358-1_77",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-642-63949-4",
"978-3-642-59358-1"
],
"name": "Acute Leukemias IX",
"type": "Book"
},
"name": "Salvage Therapy for Resistant or Relapsing Acute Lymphoblastic Leukemia (ALL) after Idarubicin-Based Induction",
"pagination": "461-464",
"productId": [
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-642-59358-1_77"
]
},
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"07517be0ebb361b20a7af2431add423397df16c822045ddf33d451d5392658ad"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1001536473"
]
}
],
"publisher": {
"location": "Berlin, Heidelberg",
"name": "Springer Berlin Heidelberg",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-642-59358-1_77",
"https://app.dimensions.ai/details/publication/pub.1001536473"
],
"sdDataset": "chapters",
"sdDatePublished": "2019-04-15T14:22",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000244.jsonl",
"type": "Chapter",
"url": "http://link.springer.com/10.1007/978-3-642-59358-1_77"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-59358-1_77'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-59358-1_77'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-59358-1_77'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-59358-1_77'
This table displays all metadata directly associated to this object as RDF triples.
193 TRIPLES
23 PREDICATES
43 URIs
20 LITERALS
8 BLANK NODES